Delivery Order SPE2DB22D3301-SPE2DB25FZ0VT
Award Date 9/11/25
Potential Completion Date 9/12/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,304.18 to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 mL vials. This is a firm fixed price, competitively awarded contract with no set-aside designation, due for completion on September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order falls under the company's existing indefinite delivery contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,102.66 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Gadavist 10 mmol/10 ml vials. This non-set-aside, firm fixed price contract is scheduled for ultimate completion by July 31, 2025, with performance occurring at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as a child...
- The Defense Logistics Agency awarded a $3,612.16 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Gadavist 7.5 mmol/7.5 ml vials. The contract, classified as firm fixed price with no set-aside designation, is scheduled for completion by September 15, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a pediatric or diagnostic imaging pharmaceutical product supporting federal medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,711.35 Firm Fixed Price Delivery Order is for the supply of Gadavist, a 1 mmol/ml bulk vial medication, with a performance period through June 13, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical to provide a...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Gadavist 10 MMOL/10 ML vials. The award, valued at $4,315.48, is a Firm Fixed Price Delivery Order with a completion date of June 24, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- The Defense Logistics Agency awarded a $1,711.35 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 30ml GADAVIST 1 MMOL/ML bulk vial pharmaceutical products. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies to the DLA Troop Support Medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $1,962.44, is for the supply of Gadavist, a 10 mmol/10 ml vial medication, with a period of performance through March 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This federal contract award, valued at $1,704.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,175,077 units of GADAVIST 1 MMOL/ML BULK VIAL 30ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 8, 2025. It is not designated as a set-aside contract, indicating open competition....
- This federal contract award, valued at $1,140.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GADAVIST 1 MMOL/ML BULK VIAL 30ML. The award is a delivery order under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies...
- This federal contract award, valued at $1,711.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4566210080 GADAVIST 1 MMOL/ML BULK VIAL 30ML, a specialty pharmaceutical product. This delivery order contract has a firm-fixed-price pricing type and an ultimate completion date of October 28, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...